- Due to the impact of a cyclosporiasis outbreak, Taco Bell's sales decline exceeded expectations.
- BUZZ - Bloom Energy shares rise due to partnership with California Resources Corporation
- BUZZ - Henry Schein shares fall; the company's third-quarter sales slightly missed expectations
- Pfizer (PFE.US) Q3 profit exceeds expectations, non-COVID products grow by 7%, full-year performance guidance raised
- Iraq and Chevron reach agreement on the West Qurna-2 oil field
- Iraq and Chevron reach agreement on West Qurna-2 oil field
- Pfizer’s revenue declined in the third quarter, dragged down by covid products.
- Strata Critical Medical Publishes Q3 2026 Earnings Call Transcript
- Jaya Raya Utama Raises Stake in Tempo Inti Media to 28.42% via Share Dividend
- EXZEO GROUP INC <XZO.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $24 FROM $25
- EQUITY LIFESTYLE PROPERTIES INC <ELS.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $63 FROM $64
- Xometry Q3 net income swings to $1.94 million; Q3 revenue rises 40% to $252.44 million
- COMMUNITY HEALTH SYSTEMS INC <CYH.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $2.5 FROM $3.25
- Fiserv swings to Q3 2026 net loss of $5.94 billion
- Strata Critical forecasts 2026 revenue of $290 million at guidance midpoint
- Everforth ECS Secures NGA Contract Extension Potentially Worth More Than $200 Million
- ALPINE INCOME PROPERTY TRUST INC : TRUIST SECURITIES CUTS TARGET PRICE TO $17 FROM $19
- Regenxbio Participates in Stifel Healthcare Conference Fireside Chat
- Danske Bank faces regulatory order over mortgage credit assessment shortcomings
- Embraer Partners With Fokker Services Group to Support Dutch C-390 Fleet
- Kirkland Lake Discoveries intersects 10.53 g/t gold over 9.2 meters at Mirado West
- Strata Critical Medical Q3 2026 net loss from continuing operations narrows 21% year-over-year to $7.62 million; Q3 2026 revenue rises 50% year-over-year to $74.08 million
- Beam Therapeutics Q3 2026 net loss widens 19% to $134.41 million
- Upstart Reports October Originations of $1.25 Billion
- Corcel Exploration plans over 3,500 meters of Phase 2 drilling at Arizona’s Yuma King project
- NextEra Energy, Dominion Energy add customer and financial safeguards to proposed deal
- Oruka Therapeutics to Present at Four Healthcare Conferences
- Hamilton Lane Q2 FY27 net income rises 44% year over year to USD 148.92 million
- MERIDIAN CORP <MRBK.O>: D.A. DAVIDSON CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $20 FROM $22
- Invivyd Grants Options for 175,000 Shares to Seven New Employees
- Keurig Dr Pepper Q3 diluted EPS rises 20% year over year to $0.59; Q3 net sales jump 71% to $7.34 billion year over year
- Labrador Gold Names Raymond Harari President
- Tango Therapeutics CEO Participates in Fireside Chat at Guggenheim Healthcare Innovation Conference
- Precision BioSciences Q3 net loss narrows 65% to $7.59 million
- DATA Communications Management publishes update to financial calendar
- Talen Energy Backs 2026 Adj EBITDA Guidance of $2.05B - $2.20B >TLN
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- Regal Rexnord Swings to Q3 Net Loss of $12.3 Million
- Madrigal Pharmaceuticals 3Q Rev $431.3M >MDGL
- Xometry Sees 2026 Adjusted Ebitda $68M-$68.5M >XMTR
- Xometry Raises 2026 Revenue Growth View to at Least 37% From 33%-34% >XMTR
- MTY Food, Lefebvre Mutually Agreed That Lefebvre Will Depart Co and Step Dn From Bd, Effective Immediately >MTY.T
- Axogen Plans Participation in Three Investor Conferences
- PALANTIR TECHNOLOGIES INC. : NORTHLAND CAPITAL RAISES TARGET PRICE TO $210 FROM $200
- Hamilton Lane Declares Quarterly Dividend of $0.60 Per Share
- Barksdale Resources Starts 8,000-Meter Drilling Phase at Sunnyside Copper Project
- Coyote Copper Secures Option to Acquire Gibson Mine for USD 1.4 Million
- INSPIRE MEDICAL SYSTEMS, INC. <INSP.N>: LEERINK PARTNERS RAISES TARGET PRICE TO $68 FROM $67
- AXSOME THERAPEUTICS, INC. : DEUTSCHE BANK CUTS TARGET PRICE TO $245 FROM $267
- Talen Energy 3Q EPS $2.88 >TLN
- MTY Food: Mandel to Step Dn as Chair and Member of Audit, Compensation, and Governance and Nominating Committees, Effective Immediately >MTY.T
- Arvinas 3Q Research and Development Expenses $46.9M >ARVN
- Xometry Sees 4Q Adjusted Ebitda $22M-$22.5M >XMTR
- Olive Resource Capital Cancels All Treasury Shares
- FirstService Residential Wins Property Management Contract for Highlands Community in Pennsylvania
- Cardiff Oncology Participates in UBS Global Biopharma Conference
- Arvinas Q3 net loss widens 54% to $53.9 million; Q3 revenue drops 99% to $500,000
- Henry Schein Raises 2026 Non-GAAP Diluted EPS Forecast to $5.50-$5.56
- Vital Farms swings to $6.46 million net loss in Q3 2026 from year-earlier profit
- Versant Media Q3 net income attributable to company drops 41% to $47 million
- ATHA ENERGY CORP <SASK.V>: VENTUM FINANCIAL INITIATES COVERAGE WITH BUY RATING; TARGET PRICE C$2
- InflaRx Plans Two Phase 2 Izicopan Trials in ANCA-Associated Vasculitis in 2027
- Upstart Q3 2026 Net Income Rises 15% YoY to $36.58 Million; Q3 2026 Revenue Climbs 34% YoY to $370.52 Million
- STAK Names Xiaofei Han Chief Financial Officer
- HEALWELL AI : STIFEL CUTS TARGET PRICE TO C$2 FROM C$2.25
- Rhythm Pharmaceuticals Q3 net loss narrows 22% year over year to $41.37 million
- Foghorn Therapeutics Plans Participation in Three Investor Conferences
- Rapport Therapeutics Participates in Stifel, Jefferies Healthcare Conferences
- BRIEF-Xometry Q3 Adjusted EPS USD 0.28 Vs. IBES Estimate USD 0.18
- C4 Therapeutics to Participate in Guggenheim and Jefferies Healthcare Conferences
- Pasithea Wins FDA Clearance for Phase 2 Trial of PAS-004 in Cutaneous Neurofibromas
- Seres Therapeutics' SER-155 cuts bloodstream infection risk 77% in Phase 1b trial
- Broadridge Financial 1Q Adj EPS $1.56 >BR
- -- GUIDANCE: (DOCN) DigitalOcean Holdings, Inc. Expects Q4 Revenue Range $348.0M - $351.0M
- --Earnings Flash (KNF) Knife River Posts Q3 EPS $2.43, vs. FactSet Est of $2.60
- -- GUIDANCE: (DOCN) DigitalOcean Holdings, Inc. Expects Q4 Adjusted EPS Range $0.30 - $0.32
- --Ladenburg Thalmann Initiates Coverage on Sportsman's Warehouse With Buy Rating
- -- Earnings Flash (ULS) UL Solutions Inc. Reports Q3 Revenue $823.0M, vs. FactSet Est of $815.7M
- --Earnings Flash (VSNT) Versant Media Posts Q3 EPS $0.34
- -- Earnings Flash (ALKS) Alkermes Posts Q3 EPS $0.09, vs. FactSet Est of $0.08 Loss
- -- Earnings Flash (DOCN) DigitalOcean Holdings, Inc. Posts Q3 Adjusted EPS $0.45 per Share, vs. FactSet Est of $0.32
- Barclays Upgrades Bloom Energy to Overweight From Equalweight, $289 Price Target
- AMETEK's Q3 Adjusted Earnings, Net Sales Increase; 2026 Outlook Raised
- -- Earnings Flash (ALKS) Alkermes Public Company Posts Q3 Revenue $480.1M, vs. FactSet Est. of $463.5M
- -- Earnings Flash (DOCN) DigitalOcean Holdings, Inc. Reports Q3 Revenue $321.2M, vs. FactSet Est of $306.7M
- TransAlta Swings to Q3 Adjusted Net Earnings, Revenue Falls
- -- Earnings Flash (RYTM) Rhythm Pharmaceuticals, Inc. Reports Q3 Revenue $92.1M, vs. FactSet Est of $85.6M
- -- Earnings Flash (SHC) Sotera Health Company Reports Q3 Revenue $324.9M, vs. FactSet Est of $319.9M
- Enpro Q3 Adjusted Earnings, Net Sales Increase; Raises 2026 Adjusted EPS Outlook
- -- Earnings Flash (SHC) Sotera Health Company Posts Q3 Adjusted EPS $0.29 per Share, vs. FactSet Est of $0.27
- --Earnings Flash (HLNE) Hamilton Lane Posts Fiscal Q2 Revenue $204.4M, vs. FactSet Est of $215.2M
- -- Earnings Flash (FISV) Fiserv, Inc. Reports Q3 Revenue $5.20B
- Top Premarket Gainers
- --GUIDANCE: (TEVA) Teva Pharmaceutical Expects 2026 Revenue Range $16.7B - $17.0B, vs. FactSet Est of $16.59B
- --Earnings Flash (HLNE) Hamilton Lane Posts Fiscal Q2 Adjusted EPS $1.98, vs. FactSet Est of $1.65
- -- Earnings Flash (TLN) Talen Energy Corporation Reports Q3 Revenue $1.33B, vs. FactSet Est of $1.30B
- -- Earnings Flash (RYTM) Rhythm Pharmaceuticals Posts Q3 Net Loss $0.61 a Share, vs. FactSet Est of $0.69 Loss
